Compassionate Treatments

For the last fifteen years, NG-1 was provided under compassionate use for over hundred patients from all over the world, suffering from life threatening neurodegenerative diseases.

These treatments were pre-approved and monitored by a special committee of the Israel Ministry of Health and the Hadassah clinical center Ethics Committee.